DK0974366T3 - Orale, farmaceutiske præparater med nedsat bitterhed ved maskering - Google Patents

Orale, farmaceutiske præparater med nedsat bitterhed ved maskering

Info

Publication number
DK0974366T3
DK0974366T3 DK98911029T DK98911029T DK0974366T3 DK 0974366 T3 DK0974366 T3 DK 0974366T3 DK 98911029 T DK98911029 T DK 98911029T DK 98911029 T DK98911029 T DK 98911029T DK 0974366 T3 DK0974366 T3 DK 0974366T3
Authority
DK
Denmark
Prior art keywords
masking
pharmaceutical preparations
oral pharmaceutical
reduced bitterness
unpleasant
Prior art date
Application number
DK98911029T
Other languages
Danish (da)
English (en)
Inventor
Koji Ukai
Yasuyuki Suzuki
Tsutomu Harada
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DK0974366T3 publication Critical patent/DK0974366T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98911029T 1997-03-28 1998-03-26 Orale, farmaceutiske præparater med nedsat bitterhed ved maskering DK0974366T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7856897 1997-03-28
JP34326597 1997-12-12
PCT/JP1998/001360 WO1998043675A1 (fr) 1997-03-28 1998-03-26 Preparations pharmaceutiques orales dont on a reduit l'amertume au moyen d'un masquant

Publications (1)

Publication Number Publication Date
DK0974366T3 true DK0974366T3 (da) 2007-01-29

Family

ID=26419628

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98911029T DK0974366T3 (da) 1997-03-28 1998-03-26 Orale, farmaceutiske præparater med nedsat bitterhed ved maskering

Country Status (9)

Country Link
US (1) US7727552B1 (fr)
EP (1) EP0974366B1 (fr)
JP (1) JP5053228B2 (fr)
KR (1) KR100693266B1 (fr)
AT (1) ATE342735T1 (fr)
DE (1) DE69836207T2 (fr)
DK (1) DK0974366T3 (fr)
ES (1) ES2273409T3 (fr)
WO (1) WO1998043675A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100801236B1 (ko) * 1998-08-28 2008-02-11 에자이 알앤드디 매니지먼트 가부시키가이샤 고미 등을 경감한 의약조성물
KR20000046974A (ko) * 1998-12-31 2000-07-25 윤재승 아세글루타미드 알루미늄의 경구 투여용 제제 조성물ㅇ
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
US6699315B2 (en) 2000-11-28 2004-03-02 Fmc Corporation Edible PGA coating composition
US7125565B2 (en) * 2000-12-01 2006-10-24 Kyowa Hakko Kogyo Co., Ltd. Composition improved in the solubility or oral absorbability
AU2003235395A1 (en) * 2002-05-22 2003-12-02 Shionogi And Co., Ltd. Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water
WO2005065645A2 (fr) * 2003-12-31 2005-07-21 Actavis Group Hf Formulations de donepezil
BRPI0822111B8 (pt) 2007-12-20 2021-05-25 Nutricia Nv composição líquida, e, uso de uma composição líquida
US20110124577A1 (en) * 2008-07-30 2011-05-26 Suntory Holdings Limited Preparation for oral administration comprises quercetin glycoside and a water-based solvent extract of cartilage containing chondroitin sulfate
US8715715B2 (en) 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
PL2243473T3 (pl) 2009-04-17 2019-01-31 Hexal Ag Tabletki zawierające środek maskujący smak
EP2366378A1 (fr) 2010-03-01 2011-09-21 Dexcel Pharma Technologies Ltd. Formulations de donépézil à libération prolongée
JP5491943B2 (ja) * 2010-04-28 2014-05-14 ゼリア新薬工業株式会社 ビタミンｂ１類含有経口ゼリー剤
WO2012037117A1 (fr) 2010-09-13 2012-03-22 Bev-Rx, Inc. Système d'administration aqueux de médicament comportant un agent masquant une saveur désagréable
EP2468254A1 (fr) 2010-12-15 2012-06-27 Hexal AG Comprimé à désintégration orale doté d'un effet de masquage du goût
CA2821919C (fr) * 2010-12-23 2015-12-15 Colgate-Palmolive Company Composition de soin buccal fluide comprenant de la gomme de gellane, de la gomme de xanthane et un sel de sodium
DK2911530T3 (en) * 2012-10-25 2017-03-20 Nestec Sa INCORPORATED BITTER PEPTIDES, PROCEDURES FOR ENCOURAGING BITTER PEPTIDES, AND NUTRITIONAL COMPOSITIONS INCLUDING THE CONTAINED BITTER PEPTIDES
CA2921308A1 (fr) 2013-08-16 2015-02-19 Universiteit Maastricht Traitement d'une deficience cognitive a l'aide d'un inhibiteur de pde4
CN106727272A (zh) * 2016-12-08 2017-05-31 星康桥医药科技（南京）有限公司 一种漱口制剂及漱口方法
WO2018124283A1 (fr) 2016-12-28 2018-07-05 富山化学工業株式会社 Composition médicinale
KR20200064951A (ko) 2018-11-29 2020-06-08 동국제약 주식회사 약리학적 활성 성분을 함유한 구강붕해필름 및 그의 제조방법
KR20230137398A (ko) 2021-01-28 2023-10-04 갈비타 아게 고체 약학 조성물 및 이의 제조 방법
EP4311543A1 (fr) 2022-07-27 2024-01-31 Galvita AG Procédés de chargement de supports inversés de modèle

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5176413A (ja) 1974-12-25 1976-07-02 Toyo Jozo Kk Hifukuzainoseizoho
JPS5476818A (en) * 1977-11-25 1979-06-19 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical composition having prolonged effect and production thereof
JPS5565741A (en) * 1978-11-10 1980-05-17 Tokico Ltd Shock absorber
GB2122892B (en) 1982-07-02 1986-01-29 Squibb & Sons Inc Nystantin pastille formulation
JPS60204712A (ja) 1984-03-29 1985-10-16 Ss Pharmaceut Co Ltd 塩酸メクリジンの安定化液状組成物
JPS61130239A (ja) 1984-11-30 1986-06-18 Dai Ichi Seiyaku Co Ltd 複合体
US5286489A (en) 1985-08-26 1994-02-15 The Procter & Gamble Company Taste masking compositions
JPS63309150A (ja) * 1987-06-11 1988-12-16 San Ei Chem Ind Ltd 即席ゲル状物の製造法
JPH0717498B2 (ja) 1989-05-31 1995-03-01 興和株式会社 鎮咳去痰ソフトカプセル剤
US5084278A (en) 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
US5013557A (en) * 1989-10-03 1991-05-07 Warner-Lambert Company Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same
US5077053A (en) 1990-02-12 1991-12-31 Warner-Lambert Company Zein as a moisture barrier for sugarless edible compositions and method for preparing same
JPH03287535A (ja) 1990-03-31 1991-12-18 Bairon Boeki Kk プラノプロフェン水溶液
JPH0418015A (ja) 1990-05-10 1992-01-22 Fujikawa Kk 安定なフマル酸クレマスチン水溶液
JP2508547B2 (ja) * 1991-01-08 1996-06-19 株式会社紀文食品 苦味低減方法及び苦味低減化組成物
JP3073544B2 (ja) * 1991-02-18 2000-08-07 三栄源エフ・エフ・アイ株式会社 塩化カリウムの脱苦味方法
JPH04282312A (ja) 1991-03-08 1992-10-07 Eisai Co Ltd コ−ティング層を有する粒状物
JP2508555B2 (ja) * 1991-05-24 1996-06-19 株式会社紀文食品 苦味低減方法
CA2068402C (fr) 1991-06-14 1998-09-22 Michael R. Hoy Enrobage pour masquer le gout pouvant etre utilise dans des comprimes pharmaceutiques croquables
DE4122217C2 (de) 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
JPH05163154A (ja) 1991-12-13 1993-06-29 Kanebo Ltd 経口液剤
RU2109509C1 (ru) 1991-12-24 1998-04-27 Яманути Фармасьютикал Ко., Лтд. Композиция для буккального введения лекарственного средства и способ ее получения
JP3069458B2 (ja) 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
JPH06218028A (ja) 1992-10-02 1994-08-09 Eisai Co Ltd 湿製錠の成型方法とその装置及び湿製錠
WO1994013257A1 (fr) 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Lotion occlusive ou semi-occlusive pour le traitement de maladies ou de desordres cutanes
ATE181672T1 (de) * 1993-04-28 1999-07-15 Takeda Chemical Industries Ltd Geschmacksmaskierte feste zubereitung und verfahren zur herstellung
CN1070896C (zh) 1993-10-01 2001-09-12 花王株式会社 屏蔽紫外线复合微粒及其生产方法和化妆品
US5576014A (en) 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
JPH07267850A (ja) 1994-03-28 1995-10-17 Eisai Co Ltd 不快味を防止した医薬組成物及びその製造方法
JP3187657B2 (ja) 1994-07-08 2001-07-11 株式会社三共製作所 錠剤製造方法およびその装置
US5672364A (en) 1994-07-07 1997-09-30 Sankyo Seisakusho Co. & Eisai Co., Ltd. Apparatus for manufacturing tablets
DE4432757A1 (de) 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
US5656284A (en) * 1995-04-24 1997-08-12 Balkin; Michael S. Oral transmucosal delivery tablet and method of making it
JPH08333245A (ja) 1995-06-07 1996-12-17 Taisho Pharmaceut Co Ltd イブプロフェン懸濁液剤
TW442287B (en) 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
SK74396A3 (en) 1995-06-13 1997-04-09 American Home Prod Organoleptically acceptable oral pharmaceutical compositions
JPH0948726A (ja) 1995-08-07 1997-02-18 Tanabe Seiyaku Co Ltd 口腔内速崩壊性製剤およびその製法
JPH09143100A (ja) 1995-11-20 1997-06-03 Sumitomo Pharmaceut Co Ltd 服用感の改善された固形製剤
US6214386B1 (en) 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
US5612026A (en) * 1996-01-25 1997-03-18 The Procter & Gamble Company Cholesterol lowering drink mix compositons
JPH103629A (ja) 1996-06-14 1998-01-06 Asahi Komagu Kk 薄膜磁気ヘッドスライダーの製造方法
RU2189227C2 (ru) 1996-07-12 2002-09-20 Дайити Фармасьютикал Ко., Лтд. Быстро распадающиеся прессованные в формах материалы и способ их получения
US5763449A (en) 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
JPH10114683A (ja) 1996-10-11 1998-05-06 Kobayashi Seiyaku Kogyo Kk 非ステロイド性解熱鎮痛消炎剤を含む固形製剤及びその製造方法
US5962535A (en) 1997-01-17 1999-10-05 Takeda Chemical Industries, Ltd. Composition for alzheimer's disease
JP4234666B2 (ja) 1997-03-28 2009-03-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 苦味等を隠蔽した経口薬剤
JP3770518B2 (ja) 1997-03-28 2006-04-26 エーザイ株式会社 苦味等を隠蔽した経口薬剤
TW580397B (en) 1997-05-27 2004-03-21 Takeda Chemical Industries Ltd Solid preparation
JP3797764B2 (ja) 1997-10-01 2006-07-19 エーザイ株式会社 光安定化組成物
TW527195B (en) 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
JPH11199517A (ja) 1997-10-31 1999-07-27 Meiji Seika Kaisha Ltd 口腔内速崩壊性錠剤
US6368625B1 (en) 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
KR100801236B1 (ko) 1998-08-28 2008-02-11 에자이 알앤드디 매니지먼트 가부시키가이샤 고미 등을 경감한 의약조성물
CA2346350C (fr) 1998-10-05 2008-01-08 Eisai Co., Ltd. Comprimes se delitant rapidement dans la cavite buccale
AU1453600A (en) 1998-11-04 2000-05-22 Mcneil-Ppc, Inc. Solid oral dosage forms containing alginic acid and famotidine
US6656492B2 (en) 2000-06-30 2003-12-02 Yamanouchi Pharmaceutical Co., Ltd. Quick disintegrating tablet in buccal cavity and manufacturing method thereof
ITMI20020686A1 (it) 2002-04-03 2003-10-03 Sitma Spa Dispositivo di stiro di una pellicola in una macchina confezionatriceautomatica di prodotti

Also Published As

Publication number Publication date
ES2273409T3 (es) 2007-05-01
EP0974366A4 (fr) 2003-03-26
ATE342735T1 (de) 2006-11-15
DE69836207T2 (de) 2007-08-30
KR100693266B1 (ko) 2007-03-27
WO1998043675A1 (fr) 1998-10-08
US7727552B1 (en) 2010-06-01
JP5053228B2 (ja) 2012-10-17
EP0974366B1 (fr) 2006-10-18
DE69836207D1 (de) 2006-11-30
JP2009051855A (ja) 2009-03-12
KR20010005510A (ko) 2001-01-15
EP0974366A1 (fr) 2000-01-26

Similar Documents

Publication Publication Date Title
EP0974366A4 (fr) Preparations pharmaceutiques orales dont on a reduit l'amertume au moyen d'un masquant
ATE109145T1 (de) Heterozyklische acylaminothiazolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DZ2887A1 (fr) Dérivés d'azétidine, leur préparation et les médicaments les contenant.
DE69606028D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
DE3580616D1 (de) Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
NL1000565C2 (nl) Complex van een insuline-analoog en protamine, dit complex bevattende farmaceutische formuleringen en bereidingswerkwijzen daarvan.
FI971986A7 (fi) Farmaseuttisia nanosuspensioita lääkeaineen antamiseen systeemeinä, joissa on kasvanut kyllästysliukoisuus ja liukenemisnopeus
FI943570A0 (fi) 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
DE69816471D1 (de) Pyrimidinon verbindungen und diese enthaltende pharmazeutische zusammenstellungen
DE68912232D1 (de) Konjugate zytotoxischer Arzneimittel.
ZA985406B (en) Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical preparations containing these compounds.
DE69014351D1 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
DE69131714D1 (de) Cephalosporine und ihre homologen, zubereitungen und pharmazeutsiche präparate
ATE297935T1 (de) 2-(iminomethyl)aminophenyl-derivate, deren herstellung, verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen
DE69909209D1 (de) Pyrimidinon-derivate, diese verbindungen enthaltenden pharmazeutische zubereitungen und verfharen zu ihrer herstellung
ATE193533T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ZA200007415B (en) Amino acid derivatives and drugs containing the same as the active ingredient.
HUP9903353A3 (en) 7alpha-(methyl-amino-pentyl)-estratrienes, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl) -estratrienes and use thereof for production of drugs
BR9811582B1 (pt) compostos derivados de 4-oxo-3,5-di-hidro-4h-piridazino[4,5-b]indol-1-acetamid a, medicamento e composição farmacêutica contendo os mesmos.
FR2675802B1 (fr) Antiserotonines, leur preparation et les medicaments les contenant.
DE68901859D1 (de) 2-benzothiazolamin-derivate enthaltende arzneimittel, verbindungen und ihre herstellung.
DE69318153D1 (de) Antihypercholesterämisch-wirksame verbindungen, pharmazeutische präparate und verwendungen davon
ZA987412B (en) 3-Arylsuccinamidohydroxamic acids, processes for their preparation, and drugs containing these substances.